Cargando…
The Role of Therapeutic Anticoagulation in COVID-19
Coagulopathy has proven to be a common complication of the novel coronavirus SARS-CoV-2, with evidence of elevated D-dimers and fibrin degradation products associated with an increased incidence of thromboembolism. Despite emerging evidence describing the coagulopathy and its clinical relevance in C...
Autores principales: | McGovern, Ruth, Conway, Patrick, Pekrul, Isabell, Tujjar, Omar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7474347/ https://www.ncbi.nlm.nih.gov/pubmed/32908713 http://dx.doi.org/10.1155/2020/8835627 |
Ejemplares similares
-
Absenteeism of Frontline Healthcare Workers During Covid-19: the Need for a Framework of Support
por: Tujjar, Omar, et al.
Publicado: (2020) -
Acute Peripheral Arterial Thrombosis in COVID-19 Patients on Therapeutic Anticoagulation
por: Kumar, Abhyuday, et al.
Publicado: (2021) -
COVID-19-Associated Coagulopathy: A Case Report of Thrombosis despite Therapeutic Anticoagulation
por: Hussain, Habiba, et al.
Publicado: (2020) -
Monitoring of COVID-19-Associated Coagulopathy and Anticoagulation with Thromboelastometry
por: Katz, Daniel, et al.
Publicado: (2021) -
Recurrent hypoglycemia and a slowly rising hemidiaphragm: A case report
por: Simpson, Vincent, et al.
Publicado: (2021)